Guangzhou KOFA Biotechnology Co.,Ltd. was founded in 2004, headquartered in Guangzhou High-tech Industry Development Zone, Science City. KOFA Biotech focuses on the research and development, manufacturing, sales and service of In Vitro Diagnostic (IVD) reagent and instrument, adhering to the concept, science and technology benefit everyone, to provide perfect quantity-value solutions and services for clinical medical diagnosis.
The aging of the world’s population has led to steady annual increase in the number of patients suffering from chronic diseases.More+
KOFA consistently adhere to the principle of "profession，strictness and preciseness" as the professional provider of high-quality and reliable products as well as close-to-customer service for the world. KOFA proficient and excellent engineering team is always ready to provide top service and professional technological support in the shortest time. Sincerely provide better and better service for all the customers.
The market for tests using cardiac biomarkers, including cardiac markers used for heart attack detection, and cholesterol and coagulation tests, surpassed $2 billion in 2015.check the details
Companies in the global in vitro diagnostic (IVD) market which is currently worth USD 60.5 billion are being affected by various trends such as hospital consolidation, China’s increasingly important role in product launch decisions, service test markets,check the details
The aging of the world’s population has led to steady annual increase in the number of patients suffering from chronic diseases.check the details
Guangzhou KOFA Biotechnology Co.,Ltd. got excellent results in the international IFCC-RELA laboratory comparison in 2020!check the details